Market Size of United States Blood Glucose Monitoring Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 14.24 Billion |
| Market Size (2029) | USD 26.23 Billion |
| CAGR (2024 - 2029) | 13.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Blood Glucose Monitoring Market Analysis
The United States Blood Glucose Monitoring Market size is estimated at USD 14.24 billion in 2024, and is expected to reach USD 26.23 billion by 2029, growing at a CAGR of 13% during the forecast period (2024-2029).
Diabetic patients were at a higher risk of hospitalizations and complications during the COVID-19 pandemic due to hyper- or hypoglycemia, metabolic comorbidities, and a more severe SARS-CoV-2 infection.The maintenance of euglycemia was important to decrease both morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe, improved inpatient glycemic outcomes, and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients.
Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Blood glucose measurement helps find out how well blood glucose is being used and how well glucose is being controlled in the body.Over time, the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. When blood glucose levels are too high or too low, they can be managed successfully, which keeps health problems related to diabetes to a minimum.
According to the National Center for Health Statistics, approximately 32.8% of adults aged 18 and over in the United States will be obese in 2021. In obese individuals, the fat cells in the body release pro-inflammatory chemicals, which may make the body less sensitive to the insulin it produces by disrupting the function of insulin-responsive cells. Thus, these individuals need external insulin shots and are obligated to use a blood glucose monitoring device, such as a glucometer.
Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients who are responsive to abnormal SMBG recordings. Such diabetes remote monitoring programs can give people with T2D who don't have it well under control the extra help they need to improve critical outcomes, which will help the market in the years to come.
